Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin

J Gastroenterol. 2001 Oct;36(10):723-4. doi: 10.1007/s005350170038.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Male
  • Myasthenia Gravis / diagnosis
  • Myasthenia Gravis / etiology*
  • Ribavirin / adverse effects*
  • Ribavirin / therapeutic use

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Ribavirin